Loxosceles intermedia Sphingomyelin phosphodiesterase D LiSicTox-alphaIA1bi-Baculovirus

• Catalog number
  GEN1014752.Baculovirus
• Price
  Please ask
• Size
  100ug

• Long name
  Recombinant Loxosceles intermedia Sphingomyelin phosphodiesterase D LiSicTox-alphaIA1bi
• Alternative names
  Phospholipase D LiSicTox-alphaIA1bi; Phospholipase D LiSicTox-alphaIA1bi; Dermonecrotic toxin 1; LiD1; LiP1; P1; Sphingomyelin phosphodiesterase D 1; SMD 1; SMase D 1; Sphingomyelinase D 1; recLiD1
• Gene name
  N/A
• Other gene names
  PLD; P1; SMD 1; SMase D 1; Sphingomyelinase D 1
• General description
  Sphingomyelin phosphodiesterase D LiSicTox-alphaIA1bi is a recombinant protein expressed in Baculovirus . The protein can be with or without a His-Tag or other tag in accordance to customer's request. All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility.
• Product category
  Recombinant Proteins
• Expression system
  Baculovirus
• Available also expressed in
  E Coli ; Yeast ; Baculovirus ; Mammalian Cell
• Purity
  Greater than 90% (determined by SDS-PAGE)
• Form
  Lyophilized protein
• Storage
  This protein can be stored at -20 degrees Celsius. For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius. Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains.
• Applications
  This protein can be used as a positive control for applications such as ELISA, IFA, RIA, Western Blot, etc.

• Gene target
  Loxosceles   intermedia   Sphingomyelin   phosphodiesterase   LiSicTox-alphaIA1bi-Baculovirus  
• Short name
  Sphingomyelin phosphodiesterase D LiSicTox-alphaIA1bi
• Alternative name
  Loxosceles intermedia Sphingomyelin phosphodiesterase D LiSicTox-alphaIA1bi-Baculovirus

MeSH Data

• Name
  Cloning, Molecular
• Concept
  Scope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
• Tree numbers
  • E05.393.220
• Qualifiers
  drug effects, methods, radiation effects

Similar products